New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and ...

There are also drugs known as calcium channel blockers, such as Amlodipine, Diltiazem ... had sex about eight times a month before, and 10 times a month after. People taking the beta-blocker ...

“All of them have 30 to 40% of their revenues coming from the US market,” he said. Companies like Dr Reddy’s Laboratories, Cipla, Sun Pharmaceutical Industries, and Aurobindo Pharma could see pressure ...

Drug major Cipla on Friday said it has received approval from the US health regulator to market a generic cancer treatment drug. The company has received the final approval from the US Food and Drug ...

Mumbai: Cipla has announced that the Company has received final approval from the United States Food and Drug Administration (USFDA) for the Abbreviated New Drug Application (‘ANDA’) submitted for ...

The company said that USFDA has approved the Abbreviated New Drug Application (ANDA) submitted for Paclitaxel Protein-bound Particles for Injectable Suspension (albumin-bound), 100 mg/vial, ...

Shares of Cipla Ltd. opened with gains of as much as 5% on Friday, after the drugmaker announced that it has received final approval from the US Food and Drug Administration (USFDA) for its ...

Cipla receives USFDA approval for its generic cancer treatment drug, paclitaxel protein-bound particles, a therapeutic equivalent to Bristol Myers Squibb's Abraxane. The drug is expected to launch in ...

Cipla's protein-bound paclitaxel is a generic therapeutic equivalent version of Bristol Myers Squibb's Abraxane for injectable suspension 100 mg/vial.

Company has received final approval from USFDA for ANDA submitted for Paclitaxel Protein-bound Particles for Injectable Suspension (albumin-bound), 100 mg/vial, Single-Dose Vial ...

The Indian stock markets, both the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) are closed today, April 10, on the occasion of Mahavir Jayanti 2025. There will be no trading ...

The US 10-year Treasury yield rose to roughly 4.5% on Wednesday, the highest level in six weeks, as investors assessed the impact of President Donald Trump’s tough tariff policy on the economy ...